Core Viewpoint - Ark Health (06086) has successfully completed a placement and subscription of shares, raising approximately HKD 144.3 million for the development of its AI-driven chronic disease management platform [1] Group 1: Share Placement and Subscription - A total of 45.181 million shares were successfully placed at a price of HKD 3.32 per share to no fewer than six subscribers [1] - The subscription was completed on February 2, 2026, with the same number of shares issued at the same price [1] - The newly issued shares represent approximately 3.26% of the company's enlarged issued share capital [1] Group 2: Use of Proceeds - Approximately 90% of the net proceeds will be used to accelerate the development of the AI-driven chronic disease management platform, including model development, infrastructure expansion, talent acquisition, data collection, and knowledge base development [1] - The remaining 10% of the proceeds will be allocated for working capital and other general corporate purposes [1]
方舟健客(06086)完成先旧后新配售4518.1万股 净筹约1.443亿港元